GT Biopharma (GTBP) FCF Margin (QoQ) (2011 - 2015)
GT Biopharma (GTBP) FCF Margin (QoQ) (2011 - 2015) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.07 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.92 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn |
| 4 | Moderna | 58.86 Bn | 53.72 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.88 Bn | 9.49 Bn | 668.28 Mn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - |
| 10 | GT Biopharma | 8.65 Mn | 8.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 1.91 Mn |
| Mar 31, 2013 | -33,080.00 |
| Dec 31, 2012 | 40,565.00 |
| Sep 30, 2012 | 3.01 Mn |
| Jun 30, 2012 | -1.11 Mn |
| Mar 31, 2012 | -840,000.00 |
| Dec 31, 2011 | -585,000.00 |
| Sep 30, 2011 | 3.44 Mn |
| Jun 30, 2011 | -3.86 Mn |
| Mar 31, 2011 | 269,227.00 |